| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_409584e3c0e57296e8d725f5c1e682a4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-676 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D463-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D463-22 |
| filingDate |
2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c3865c80b40177f6f51e05e5a8131c7 |
| publicationDate |
2020-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020008183-A1 |
| titleOfInvention |
Intermediates in the synthesis of c3-substituted cephalosporins |
| abstract |
Disclosed herein are novel and inventive methods for preparing intermediates in the synthesis of C3-substituted cephalosporins. One preferred C3-substituted cephalosporin of clinical interest is Cefovecin. Accordingly, the present invention provides for methods of preparing reactive halogen intermediates for use in the synthesis of C3-substituted cephalosporins, such as Cefovecin. In the case of Cefovecin the reactive intermediates are of the formula (I). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112409382-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111763221-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111892612-A |
| priorityDate |
2018-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |